
News and highlights
A selection of research highlights, instrument news and technical developments for scientists.
Showing 1 - 20 of 1378 results
A selection of research highlights, instrument news and technical developments for scientists.
Links to all previous news and case studies published by the National Deuteration Facility
Collaboration finds that old carbon reservoirs are unlikely to cause a massive greenhouse gas release in a warming world.
Lutetium-177 used for advanced prostate cancer
Planetary science is an emerging research theme in Australia, and research at ANSTO is embedded in the heart of this.
ANSTO is engaged in international partnerships in the peaceful uses of nuclear science and technology throughout the world.
Join us for this online webinar to explore and discuss the huge opportunities in growing a dynamic and impactful future nuclear workforce.
Connect with the businesses and organisations seeking better understanding decommissioning oil and gas infrastructure and the potential impact of contaminants on marine life.
Connect with the businesses and organisations driving advanced manufacturing and supporting green technologies.
2022 has been a big year for ANSTO with contributions to the advanced manufacturing, space, food, energy industries, and more. As we set our sights on 2023, we thought we’d take the opportunity to share some of our key innovation achievements from this year.
ANSTO has contributed to work by scientists from the Tokyo Institute of Technology on a promising proton conductor for next-generation ceramic fuel cells.
The National Deuteration Facility offers the facilities and expertise to produce molecules where all or part of the molecular hydrogen is replaced with deuterium. This enables complex investigations of the relationship between the structure of molecules and their function using neutron scattering and other techniques.
Collaboration investigates a promising new nanoparticle for potential use in combination with other therapies for brain cancer
Australia and Sri Lanks signs new partnership to fight chronic kidney disease.